Why is Remedium Life falling/rising?

As of 26-Aug, Remedium Lifecare Ltd is experiencing a decline in its stock price, currently at 1.28, which reflects a decrease of 0.05 or 3.76%. The stock has underperformed its sector by 1.79% today, and its trading volume has significantly decreased, with a delivery volume drop of 57.6% compared to the 5-day average. Over the past week, the stock has fallen by 2.29%, while it has shown a marginal increase of 3.23% over the past month. However, the long-term performance is concerning, with a staggering decline of 80.58% over the past year and negative results reported for the last four consecutive quarters, indicating a poor financial outlook. The company faces challenges such as a high Debt to EBITDA ratio and negative operating profit growth, which contribute to its weak stock performance.
In the broader market context, the Sensex has declined by only 1.05% over the past week, indicating that Remedium Lifecare Ltd's performance is significantly worse than the market average. While the stock has shown some resilience over a three-year period with a return of 53.80%, its year-to-date performance is dismal at -64.19%, contrasting sharply with the Sensex's positive return of 3.39%. This stark difference highlights the company's struggles relative to the overall market, further exacerbated by its negative EBITDA and inability to service debt, making it a risky investment.